Cannabis in Switzerland

Cannabis in Switzerland

Following the current liberalisation of medical cannabis, the trend towards liberalisation of adult-use cannabis is also expected over the forecast period. The consumption of products bought on the black market carries the risk of containing dangerous harmful substances or synthetic cannabinoids. For this reason, Swiss authorities will likely seek a compromise between prohibition and absolute legalisation of cannabis. Over the next few years, more pilot projects are expected to take place in ord...

Euromonitor International's Cannabis in Switzerland market report offers a comprehensive guide to the size and shape of this emerging market opportunity at a national level. It provides the latest retail sales data (historic date range), allowing you to identify the key cannabinoid categories driving growth. It outlines the regulatory, cultural and commercial context and offers strategic analysis of key factors influencing the market – legislative developments both current and future, economic/lifestyle influences, illicit consumption, product innovation, distribution and pricing trends. Forecasts to 2027 illustrate how the market is set to expand and change.

Product coverage: Adult-Use Cannabis, CBD, Medical Cannabis.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
* Get a detailed picture of the Cannabis market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.